You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

refractory glioblastoma multiforme

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab)

Recruiting
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • New York, New York
    Lenox Hill Brain Tumor Center
Nov 10, 2022

Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma Trial in New York (Intra-arterial Cetuximab, Intra-arterial

Recruiting
  • Glioblastoma
  • +8 more
  • Intra-arterial Cetuximab
  • +2 more
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 17, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in New York (Bevacizumab and Carboplatin)

Suspended
  • Glioblastoma Multiforme
  • Anaplastic Astrocytoma
  • Bevacizumab and Carboplatin
  • New York, New York
    Lenox Hill Brain Tumor Center
Oct 27, 2021

Glioblastoma Multiforme Trial in Chapel Hill (CAR.B7-H3T cells infusion)

Recruiting
  • Glioblastoma Multiforme
  • CAR.B7-H3T cells infusion
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Oct 25, 2022

Glioblastoma Multiforme, Anaplastic Astrocytoma, Fibrillary Astrocytomas Trial in Miami (SIACI of cetuximab and bevacizumab)

Not yet recruiting
  • Glioblastoma Multiforme
  • +4 more
  • SIACI of cetuximab and bevacizumab
  • Miami, Florida
    Jackson Memorial Hospital
Jul 14, 2023

Malignant Supratentorial Tumor, Recurrent Glioblastoma, Recurrent Gliosarcoma Trial in Houston (Lonafarnib, Temozolomide)

Active, not recruiting
  • Malignant Supratentorial Neoplasm
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 13, 2021

Glioma, Glioma, Malignant, Glioblastoma Trial in New York (Laparoscopically harvested omental tissue autograft)

Recruiting
  • Glioma
  • +7 more
  • Laparoscopically harvested omental tissue autograft
  • New York, New York
    Lenox Hill Brain Tumor Center
Jul 31, 2023

A Close Examination of Patient Experiences in Glioblastoma

Not yet recruiting
  • Glioblastoma Multiforme
    • San Francisco, California
      Power Life Sciences
    Jul 14, 2023

    Deuterium Metabolic Imaging to Assess Radiotherapy Changes in

    Not yet recruiting
    • Glioblastoma Multiforme
    • Deuterium metabolic imaging
    • Aarhus, Denmark
      Aarhus University
    Jun 6, 2023

    [18F]FPIA PET-CT in Glioblastoma Multiforme (GBM)

    Recruiting
    • Glioblastoma Multiforme of Brain
    • Positron Emission Tomography-Computerised Tomography (PET-CT)
    • London, United Kingdom
      Imperial College Healthcare NHS Trust
    Mar 23, 2023

    Glioblastoma Multiforme Trial in Shijia Zhuang (TMZ)

    Recruiting
    • Glioblastoma Multiforme
    • Shijia Zhuang, Hebei, China
      the Second Hospital of HeBei Medical University
    Oct 18, 2022

    Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

    Recruiting
    • Glioblastoma Multiforme
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Mar 13, 2023

    Glioblastoma Multiforme Trial in United States (Bevacizumab, BKM120)

    Completed
    Has Results
    • Glioblastoma Multiforme
    • New Haven, Connecticut
    • +7 more
    Jun 8, 2020

    New Antigens Against Glioblastoma

    Not yet recruiting
    • Glioblastoma Multiforme
      • (no location specified)
      Jun 15, 2023

      Glioblastoma Multiforme Trial in Brno (11C-Methionine PET/CT)

      Recruiting
      • Glioblastoma Multiforme
      • 11C-Methionine PET/CT
      • Brno, Czech Republic, Czechia
        Masaryk Memorial Cancer Institute
      Nov 3, 2022

      Glioblastoma Multiforme of Brain Trial in Gatineau (avelumab)

      Completed
      • Glioblastoma Multiforme of Brain
      • avelumab
      • Gatineau, Quebec, Canada
        Clinique Neuro-Outaouais
      Jul 19, 2022

      Glioblastoma Multiforme (GBM) Trial in Taoyuan (ADI-PEG20, Temozolomide)

      Recruiting
      • Glioblastoma Multiforme (GBM)
      • Taoyuan, Taiwan
        Chang Gung Memorial Hospital, Linkou Branch
      Sep 29, 2022

      Glioblastoma, Glioblastoma Multiforme Trial (APG-157)

      Available
      • Glioblastoma
      • Glioblastoma Multiforme
      • (no location specified)
      Sep 19, 2022

      Glioblastoma Multiforme Trial in Philadelphia (Bevacizumab)

      Recruiting
      • Glioblastoma Multiforme
      • Philadelphia, Pennsylvania
        (unnamed)
      Aug 8, 2022

      Glioblastoma Multiforme, Anaplastic Astrocytoma, Gliosarcoma Trial in Birmingham (M032, Pembrolizumab)

      Recruiting
      • Glioblastoma Multiforme
      • +2 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Jan 30, 2023

      Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

      Not yet recruiting
      • Glioblastoma Multiforme of Brain
      • TVI-Brain-1
      • +3 more
      • (no location specified)
      Jan 13, 2023

      Glioma, Malignant, Glioblastoma, Glioblastoma Multiforme Trial in New York (Tissue autograft of pedicled temporoparietal fascial

      Recruiting
      • Glioma, Malignant
      • +6 more
      • Tissue autograft of pedicled temporoparietal fascial (TPF) or pericranial flap to bypass the blood brain barrier (BBB)
      • New York, New York
        Lenox Hill Brain Tumor Center
      Jul 13, 2023

      During MR-guided Radiation Therapy for Glioblastoma

      Recruiting
      • Glioblastoma Multiforme
      • Low field (0.35 T) MR-images of the brain at a MRIdian® linac system
      • Zürich, Zurich, Switzerland
        University Hospital Zurich
      Sep 29, 2022

      Glioblastoma Multiforme Trial (Atezolizumab + FSRT radiation)

      Not yet recruiting
      • Glioblastoma Multiforme
      • Atezolizumab + FSRT radiation
      • (no location specified)
      Jun 14, 2022

      Glioblastoma Multiforme of Brain, Glioblastoma Multiforme Trial in Shenzhen (Antigen-specific IgT cells)

      Enrolling by invitation
      • Glioblastoma Multiforme of Brain
      • Glioblastoma Multiforme
      • Antigen-specific IgT cells
      • Shenzhen, Guangdong, China
      • +1 more
      Nov 23, 2021